| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD-0332991 | GDSC1000 | pan-cancer | AAC | -0.29 | 2e-17 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | -0.26 | 3e-14 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.16 | 4e-06 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-06 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.14 | 2e-05 |
| mRNA | Midostaurin | GDSC1000 | pan-cancer | AAC | -0.14 | 8e-05 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0003 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.0004 |